Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology

INTRODUCTION: The level of the presynaptic protein growth-associated protein 43 (GAP-43) in cerebrospinal fluid (CSF) has previously been shown to be increased in Alzheimer’s disease (AD) and thus may serve as an outcome measure in clinical trials and facilitate earlier disease detection. METHODS: W...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement
Main Authors: Sandelius, Åsa, Portelius, Erik, Källén, Åsa, Zetterberg, Henrik, Rot, Uros, Olsson, Bob, Toledo, Jon B., Shaw, Leslie M., Lee, Virginia M. Y., Irwin, David J., Grossman, Murray, Weintraub, Daniel, Chen-Plotkin, Alice, Wolk, David A., McCluskey, Leo, Elman, Lauren, Kostanjevecki, Vesna, Vandijck, Manu, McBride, Jennifer, Trojanowski, John Q., Blennow, Kaj
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6333489/
https://ncbi.nlm.nih.gov/pubmed/30321501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2018.08.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados